On June 10, 2021 Vaccibody AS, a clinical-stage biopharmaceutical company dedicated to the discovery and development of vaccines and novel immunotherapies, reported that its CEO, Michael Engsig, and Chief Innovation & Strategy Officer, Agnete Fredriksen, will give a presentation of Vaccibody at Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021 at 2.10 pm EDT / 8.10 pm CET (Press release, Vaccibody, JUN 10, 2021, View Source/wp-content/uploads/2021/06/210610_PR_Goldman-Sachs-42nd-Annual-Global-Healthcare-Conference-FINAL.pdf" target="_blank" title="View Source/wp-content/uploads/2021/06/210610_PR_Goldman-Sachs-42nd-Annual-Global-Healthcare-Conference-FINAL.pdf" rel="nofollow">View Source [SID1234583799]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live presentation may be viewed here: View Source Further, the slide presentation will be available on Vaccibody’s website at View Source